21,572 Shares in Corteva, Inc. (NYSE:CTVA) Acquired by Silverleafe Capital Partners LLC

Silverleafe Capital Partners LLC acquired a new position in shares of Corteva, Inc. (NYSE:CTVA) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 21,572 shares of the company’s stock, valued at approximately $1,244,000. Corteva makes up approximately 0.5% of Silverleafe Capital Partners LLC’s investment portfolio, making the stock its 29th largest holding.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Register Financial Advisors LLC purchased a new position in Corteva during the 1st quarter worth approximately $106,000. Artemis Investment Management LLP purchased a new position in shares of Corteva during the 1st quarter valued at $63,238,000. Cardinal Capital Management grew its holdings in shares of Corteva by 5.6% during the 1st quarter. Cardinal Capital Management now owns 25,326 shares of the company’s stock valued at $1,461,000 after acquiring an additional 1,349 shares in the last quarter. Janiczek Wealth Management LLC grew its holdings in shares of Corteva by 27.1% during the 1st quarter. Janiczek Wealth Management LLC now owns 2,252 shares of the company’s stock valued at $130,000 after acquiring an additional 480 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC grew its holdings in shares of Corteva by 20.0% during the 1st quarter. Wealthcare Advisory Partners LLC now owns 6,435 shares of the company’s stock valued at $371,000 after acquiring an additional 1,074 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Corteva

In other Corteva news, SVP Cornel B. Fuerer sold 39,736 shares of the company’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the sale, the senior vice president now directly owns 126,628 shares of the company’s stock, valued at $7,269,713.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Corteva news, SVP Cornel B. Fuerer sold 39,736 shares of the company’s stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $57.41, for a total transaction of $2,281,243.76. Following the sale, the senior vice president now directly owns 126,628 shares of the company’s stock, valued at $7,269,713.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Samuel R. Eathington sold 31,686 shares of the company’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the sale, the insider now directly owns 53,854 shares in the company, valued at $3,104,144.56. The disclosure for this sale can be found here. Insiders have sold a total of 83,556 shares of company stock valued at $4,795,016 over the last quarter. 0.14% of the stock is owned by company insiders.

Corteva Stock Up 0.5 %

Shares of CTVA opened at $53.94 on Friday. The firm has a market capitalization of $37.60 billion, a P/E ratio of 68.28, a P/E/G ratio of 1.43 and a beta of 0.78. The company has a 50-day simple moving average of $54.77 and a 200-day simple moving average of $52.73. Corteva, Inc. has a 52 week low of $43.22 and a 52 week high of $58.76. The company has a debt-to-equity ratio of 0.10, a quick ratio of 0.97 and a current ratio of 1.51.

Corteva (NYSE:CTVA) last posted its earnings results on Wednesday, May 1st. The company reported $0.89 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. The business had revenue of $4.49 billion for the quarter, compared to analysts’ expectations of $4.65 billion. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The firm’s revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.16 earnings per share. On average, equities research analysts expect that Corteva, Inc. will post 2.8 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Tuesday, June 4th were paid a $0.16 dividend. The ex-dividend date of this dividend was Tuesday, June 4th. This represents a $0.64 dividend on an annualized basis and a yield of 1.19%. Corteva’s payout ratio is currently 81.01%.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Wolfe Research assumed coverage on shares of Corteva in a report on Friday, March 1st. They set an “outperform” rating and a $67.00 price target on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $57.00 price objective (down previously from $58.00) on shares of Corteva in a research note on Friday, April 12th. OTR Global reaffirmed a “negative” rating on shares of Corteva in a research note on Friday, June 7th. Oppenheimer lifted their price objective on shares of Corteva from $67.00 to $69.00 and gave the company an “outperform” rating in a research note on Friday, May 3rd. Finally, KeyCorp lifted their price objective on shares of Corteva from $63.00 to $66.00 and gave the company an “overweight” rating in a research note on Tuesday, April 9th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and a consensus target price of $63.00.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.